| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $430K | +317.5% |
| Cost of Revenue | $270K | +1025.0% |
| R&D Expense | $2.3M | -24.6% |
| SG&A Expense | $5.0M | -12.1% |
| Operating Income | -$7.7M | +14.1% |
| Net Income | -$7.7M | +13.6% |
| EPS (Basic) | -$0.52 | +22.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.5M | +475.5% |
| Accounts Receivable | $231K | +5675.0% |
| Inventory | $80K | +60.0% |
| Current Assets | $3.2M | +313.0% |
| Total Assets | $4.4M | +69.9% |
| Current Liabilities | $1.0M | +5.5% |
| Total Liabilities | $1.2M | +26.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.9M | +30.1% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $6.9M | +12.6% |
| Free Cash Flow | -$4.9M | +30.2% |
| Stockholders' Equity |
| $3.2M |
| +95.7% |